-
2022-501939-16-00
5
2023-05-09
Heart failure (HF) with mildly reduced ejection fraction (HFmrEF) or H
-
2023-509320-17-00
6
2023-03-28
non-radiographic axial spondyloarthritis
-
2023-504741-32-00
4
2022-11-30
Moderately to Severely Active Crohn's Disease
-
2023-504743-13-00
4
2022-11-30
Moderately to Severely Active Ulcerative Colitis
-
2024-511581-37-00
6
2022-11-25
Respiratory Tract Infections with Wheezing Lower Respiratory Illness
-
2023-504740-33-00
5
2022-11-22
Fistulizing perianal Crohn's Disease
-
2023-505772-30-00
5
2022-11-09
Melanoma
-
2023-505628-67-00
5
2022-10-28
Relapsed and Refractory Follicular Lymphoma
-
2023-505579-53-00
5
2022-10-25
Diffuse large B-cell lymphoma (DLBCL)
-
2024-511126-31-00
5
2022-08-16
Non-obstructive Coronary Artery Disease
-
2024-511068-10-00
5
2022-08-04
Sjögren’s Syndrome
-
2023-504996-26-00
5
2022-07-21
Metastatic Castration Resistant Prostate Cancer (mCRPC)
-
2024-516315-24-00
5
2022-05-27
myopia
-
2023-503640-14-00
5
2022-02-17
Newly diagnosed Philadelphia-negative B-cell precursor Acute Lymphobla
-
2023-504884-17-00
5
2022-02-04
Proteinuria
-
2022-501067-40-00
5
2021-11-30
Moderately to Severely Active Ulcerative Colitis
-
2024-510735-21-00
5
2021-11-26
Atherosclerotic cardiovascular disease (ASCVD)
-
2023-504715-33-00
5
2021-09-27
Psoriatic Arthritis
-
2023-508723-12-00
5
2021-09-27
gastroenteropancreatic neuroendocrine tumors
-
2023-506926-35-00
5
2021-09-24
Atherosclerotic cardiovascular disease, chronic kidney disease and sys
-
2023-508690-92-00
11
2021-09-20
IgA Nephropathy
-
2024-512038-13-00
5
2021-09-16
Metastatic or unresectable locally advanced BRAF V600E/K mutation posi
-
2023-506368-14-00
5
2021-09-07
Systemic lupus erythematosus (SLE)
-
2023-504734-21-00
5
2021-08-30
Psoriatic arthritis (PsA)